Analystreport

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at SVB Leerink LLC from $785.00 to $798.00. They now have an "outperform" rat

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com